---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-032266"
form_type: "8-K"
ticker: "XFOR"
cik: "0001501697"
company_name: "X4 Pharmaceuticals, Inc"
filed_at: "2024-07-19T23:59:59+00:00"
generated_at: "2026-05-31T19:00:53.133439+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# X4 Pharmaceuticals updates corporate presentation; no material new details provided

## Summary
- Posted updated corporate presentation on company website on July 19, 2024.
- Presentation available in Investors section of www.x4pharma.com.
- No specific financial or operational updates disclosed in the 8-K filing.

## SEC filing metadata
- accession: 0001628280-24-032266
- form_type: 8-K
- ticker: XFOR
- cik: 0001501697
- company_name: X4 Pharmaceuticals, Inc
- filed_at: 2024-07-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501697/000162828024032266/0001628280-24-032266-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501697/000162828024032266/xfor-20240719.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-032266
- JSON: https://secwatch.observer/filing/0001628280-24-032266.json
- Plain text: https://secwatch.observer/filing/0001628280-24-032266.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.